BibliographyBinding of the anti-progestin RU-<strong>486</strong> to rat ovary steroid receptors.Contraception 28:77–81.Secher, N.J., Thayssen, P, Arnsbo, P. <strong>and</strong> Olsen, J. (1982). Effect ofprostagl<strong>and</strong>in E2 <strong>and</strong> F2 on the systemic <strong>and</strong> pulmonary circulationin pregnant anaesthetized women. Acta Obstetrica et GynecologicaSc<strong>and</strong>inavica 63:213–218.Segal, Sheldon J. (1990). Mifepristone (RU <strong>486</strong>). The New Engl<strong>and</strong>Journal of Medicine 322:691–693.Shi Wenliang <strong>and</strong> Zhu Pengdi. (1990). Autoradiographic localizationof [3H] RU <strong>486</strong> <strong>and</strong> [3H] progesterone in the uterus, pituitary<strong>and</strong> hypothalamus of the rat. Human Reproduction 5 (2): 123–127.Shoupe, Donna, Mishell, Daniel R., Page, Mary Alice, Madkour,Hosam, Spitz, Irving M. <strong>and</strong> Lobo, Rogerio A. (1987). Effects ofthe antiprogesterone RU <strong>486</strong> in normal women. II. Administrationin the late follicular phase. American Journal of Obstetrics <strong>and</strong> Gynecology157:1421–1426.Silvestre, Louise, Dubois, Catherine, Renault, Maguy, Rezvani,Yvonne, Baulieu, Etienne-Emile <strong>and</strong> Ulmann, André. (1990).Voluntary interruption of pregnancy with Mifepristone (RU <strong>486</strong>)<strong>and</strong> a prostagl<strong>and</strong>in analogue. The New Engl<strong>and</strong> Journal of Medicine322:645–648.Simmons, Katie <strong>and</strong> Savage, Wendy. (1984). Neonatal death associatedwith induction of labour with intravaginal prostagl<strong>and</strong>in E2. BritishJournal of Obstetrics <strong>and</strong> Gynaecology 91: 598–599.Simons, Marlise. (1988, 28 October). A medical outcry greetssuspension of abortion pill. The New York Times: A1 <strong>and</strong> A8.Sitruk-Ware, R., Bilaud, L., Mowszowicz, I., Yaneva, H., Mauvais-Jarvis, P., Bardin, C.W. <strong>and</strong> Spitz, I.M. (1985). The use of RU<strong>486</strong> as an abortifacient in early pregnancy. In: The AntiprogestinSteroid RU<strong>486</strong> <strong>and</strong> Human Fertility Control, edited by E.-E.Baulieu<strong>and</strong> S.Segal. Plenum Press: New York: 243–247.Sitruk-Ware, Regine, Thalabard, Jean-Christophe, De Plunkett, TuLan, Lewin, Fanny, Epelboin, Sylvie, Mowszowicz, Irene, Yaneva,147
RU <strong>486</strong>148Halina, Tournaire, Michel, Chavinie, Jacques, Mauvais-Jarvis,Pierre <strong>and</strong> Spitz, Irving. (1990). The use of the antiprogestin RU<strong>486</strong> (mifepristone) as an abortifacient in early pregnancy- clinical<strong>and</strong> pathological findings; predictive factors for efficacy.Contraception 41:221–243.Somell, Christina <strong>and</strong> Ölund, Anders. (1990). Induction of abortionin early pregnancy with mifepristone. Gynecologic <strong>and</strong> ObstetricInvestigations 29:13–15.Sontag, S.J., Mazure, P.A., Pontes, J.F., Beker, S.G. <strong>and</strong> Dajani, E.Z.(1985). Misoprostol in the treatment of duodenal ulcer. Amulticenter double-blind placebo-controlled study. Digestive Diseases<strong>and</strong> Sciences 30:159S–163S.Stuenkel, Cynthia A., Garzo, V. Gabriel, Morris, Stephen, Liu, JamesH. <strong>and</strong> Yen, Samuel S.C. (1990). Effects of the antiprogesteroneRU <strong>486</strong> in the early follicular phase of the menstrual cycle. Fertility<strong>and</strong> Sterility 53:642–646.Sunday Times Magazine (UK). (1988, 30 October). French AbortionPill on Sale Here in 1990.Swahn, Marja-Liisa <strong>and</strong> Bygdeman, Marc. (1987). Interruption of earlygestation with prostagl<strong>and</strong>ins <strong>and</strong> antiprogestin. In: FertilityRegulation Today <strong>and</strong> Tomorrow, edited by E.Diczfalusy <strong>and</strong>M.Bygdeman, Raven Press: New York: 109–118.Swahn, Marja-Liisa <strong>and</strong> Bydgeman, Marc. (1989). Termination of earlypregnancy with RU <strong>486</strong> (Mifepristone) in combination with aprostagl<strong>and</strong>in analogue (Sulprostone). Acta Obstetrica GynecologicaSc<strong>and</strong>inavica 68:293–300.Swahn, Marja-Liisa, Gottlieb, C., Green, Krister <strong>and</strong> Bygdeman, Marc.(1990). Oral administration of RU <strong>486</strong> <strong>and</strong> 9-methylene PGE 2for termination of early pregnancy. Contraception 41:461–473.The Feminist Majority Foundation (1990). RU <strong>486</strong> Communiqué (n.d;n.pp).Tonti-Filippini, Nicholas. (1990). RU <strong>486</strong>: Dispelling Some <strong>Myths</strong>. StVincent’s Bioethics Centre, Newsletter (June) 8 (2): 11–14.Ulmann, André, Dubois, Catherine <strong>and</strong> Philibert, Daniel. (1987).Fertility control with RU <strong>486</strong>. Hormone Research 28:274–278.
- Page 2 and 3:
Renate Klein is Lecturer in Women
- Page 4 and 5:
RU 486Misconceptions,Myths and Mora
- Page 6 and 7:
ACKNOWLEDGEMENTSWe would like to ex
- Page 8 and 9:
CONTENTSINTRODUCTION 1CHAPTER ONETh
- Page 10 and 11:
INTRODUCTIONInitial euphoria greete
- Page 12 and 13:
IntroductionUnfortunately, objectio
- Page 14 and 15:
Introductiondo not know or do not a
- Page 16 and 17:
Introductionused widely for years a
- Page 18 and 19:
CHAPTER ONEThe History of RU 486RU
- Page 20 and 21:
The History of RU 486consultants ar
- Page 22 and 23:
The History of RU 486Events in Fran
- Page 24 and 25:
The History of RU 486service of wom
- Page 26 and 27:
The History of RU 486The result app
- Page 28 and 29:
The History of RU 486developing cou
- Page 30 and 31:
The History of RU 486University Hos
- Page 32 and 33:
The History of RU 486pharmacovigila
- Page 34 and 35:
CHAPTER TWOClaims for RU 486/PG Abo
- Page 36 and 37:
Claims for RU 486/PG Abortionsevera
- Page 38 and 39:
Claims for RU 486/PG Abortionthe Br
- Page 40 and 41:
Claims for RU 486/PG Abortionan imm
- Page 42 and 43:
Claims for RU 486/PG Abortionby the
- Page 44 and 45:
Claims for RU 486/PG Abortionby the
- Page 46 and 47:
Claims for RU 486/PG Abortionfrom A
- Page 48 and 49:
Claims for RU 486/PG Abortioncommen
- Page 50 and 51:
Claims for RU 486/PG AbortionSome s
- Page 52 and 53:
Claims for RU 486/PG Abortionbreeze
- Page 54 and 55:
Claims for RU 486/PG Abortion18 per
- Page 56 and 57:
Claims for RU 486/PG Abortion1. RU
- Page 58 and 59:
Claims for RU 486/PG AbortionRU 486
- Page 60 and 61:
Claims for RU 486/PG Abortionwider
- Page 62 and 63:
Claims for RU 486/PG Abortionmedica
- Page 64 and 65:
Claims for RU 486/PG Abortionreligi
- Page 66 and 67:
What Is RU 486 and How Does It Work
- Page 68 and 69:
What Is RU 486 and How Does It Work
- Page 70 and 71:
What Is RU 486 and How Does It Work
- Page 72 and 73:
What Is RU 486 and How Does It Work
- Page 74 and 75:
What Is RU 486 and How Does It Work
- Page 76 and 77:
What Is RU 486 and How Does It Work
- Page 78 and 79:
What Is RU 486 and How Does It Work
- Page 80 and 81:
What Is RU 486 and How Does It Work
- Page 82 and 83:
What Is RU 486 and How Does It Work
- Page 84 and 85:
What Is RU 486 and How Does It Work
- Page 86 and 87:
What Is RU 486 and How Does It Work
- Page 88 and 89:
What Is RU 486 and How Does It Work
- Page 90 and 91:
The Role of Prostaglandins: Known a
- Page 92 and 93:
The Role of Prostaglandins: Known a
- Page 94 and 95:
The Role of Prostaglandins: Known a
- Page 96 and 97:
The Role of Prostaglandins: Known a
- Page 98 and 99:
The Role of Prostaglandins: Known a
- Page 100 and 101:
The Role of Prostaglandins: Known a
- Page 102 and 103:
The Role of Prostaglandins: Known a
- Page 104 and 105:
The Role of Prostaglandins: Known a
- Page 106 and 107: The Role of Prostaglandins: Known a
- Page 108 and 109: The Role of Prostaglandins: Known a
- Page 110 and 111: The Role of Prostaglandins: Known a
- Page 112 and 113: The Role of Prostaglandins: Known a
- Page 114 and 115: The Role of Prostaglandins: Known a
- Page 116 and 117: The Role of Prostaglandins: Known a
- Page 118 and 119: The Role of Prostaglandins: Known a
- Page 120 and 121: The Role of Prostaglandins: Known a
- Page 122 and 123: ConclusionInstead, Baulieu uses the
- Page 124 and 125: Conclusionintervention. Thus, RU 48
- Page 126 and 127: Conclusionbetween population contro
- Page 128 and 129: ConclusionThis article, appearing i
- Page 130 and 131: Conclusion‘a whole net of relatio
- Page 132 and 133: ENDNOTESChapter One1The paten t lic
- Page 134 and 135: Endnotes12The Journal Officiel publ
- Page 136 and 137: Endnotesin Gynecology and Obstetric
- Page 138 and 139: Endnotesof menses. On the third day
- Page 140 and 141: EndnotesAnother such example is the
- Page 142 and 143: Bibliographyand Segal, Sheldon (Eds
- Page 144 and 145: Bibliographyprostaglandin F 2•. A
- Page 146 and 147: BibliographyDelaney, Anne. (1991, 2
- Page 148 and 149: Bibliographyresponses to the steroi
- Page 150 and 151: Bibliographyabnormalities resulting
- Page 152 and 153: Bibliographyprogesterone receptor b
- Page 154 and 155: BibliographyOdlind, Viveca and Birg
- Page 158 and 159: BibliographyUlmann, André, Teutsch
- Page 160: Bibliographytermination by vacuum a